Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children

BACKGROUND: Urinary schistosomiasis, the result of infection by Schistosoma haematobium (Sh), remains a major global health concern. A schistosome vaccine could represent a breakthrough in schistosomiasis control strategies, which are presently based on treatment with praziquantel (PZQ). We report t...

Descripción completa

Detalles Bibliográficos
Autores principales: Riveau, Gilles, Schacht, Anne-Marie, Dompnier, Jean-Pierre, Deplanque, Dominique, Seck, Modou, Waucquier, Nawal, Senghor, Simon, Delcroix-Genete, Delphine, Hermann, Emmanuel, Idris-Khodja, Noureddine, Levy-Marchal, Claire, Capron, Monique, Capron, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300301/
https://www.ncbi.nlm.nih.gov/pubmed/30532268
http://dx.doi.org/10.1371/journal.pntd.0006968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300301/
https://www.ncbi.nlm.nih.gov/pubmed/30532268
http://dx.doi.org/10.1371/journal.pntd.0006968

Ejemplares similares